Synchrony Financial
SYF
$72.90
+1.57%
Synchrony Financial is the largest provider of private-label credit cards in the United States, operating through retail card, payment solutions, and CareCredit segments. As a dominant player in consumer credit, it partners with major retailers and healthcare providers to offer financing solutions. The current investor narrative centers on improving credit metrics and consumer resilience despite inflationary pressures, with a focus on capital return programs and buyback activity signaling management confidence.…
SYF
Synchrony Financial
$72.90
Related headlines
Investment Opinion: Should I buy SYF Today?
Rating: Buy. Synchrony Financial offers a compelling risk/reward with accelerating revenue growth, expanding margins, and a forward P/E of 7.0x that is well below the market. The consensus analyst rating is Buy with an average target of $89.83, implying 22% upside. The core thesis is that improving credit metrics and consumer resilience will drive earnings growth, while the stock's valuation provides a margin of safety.
Supporting Evidence: Revenue grew 16.6% YoY in Q1 2026, the fastest pace in recent quarters. Net margin expanded to 18.6% from 15.8% a year ago, and operating margin improved to 24.2%. Free cash flow of $2.183B in Q1 2026 supports the buyback program, which reduced shares outstanding by 11% over the past year. The forward P/E of 7.0x is a 30% discount to the sector average, and the PEG ratio of 1.09 suggests reasonable valuation relative to growth.
Risks & Conditions: The biggest risks are a consumer credit downturn and regulatory changes. If net charge-offs rise above 3.5%, earnings could disappoint, and the stock could fall to the low target of $78. This Buy rating would be downgraded to Hold if revenue growth decelerates below 10% or if the forward P/E expands above 9x. Conversely, if credit metrics continue to improve and the stock breaks above $80, it could be upgraded to Strong Buy. Overall, Synchrony appears undervalued relative to its growth and profitability, offering a favorable entry point for value-oriented investors.
Sign up to view all
SYF 12-Month Price Forecast
Synchrony Financial presents a strong risk/reward profile with accelerating revenue growth, expanding margins, and a deeply discounted valuation. The forward P/E of 7.0x is well below the market, and the average analyst target implies 22% upside. However, the stock's high beta and sensitivity to consumer credit conditions introduce uncertainty. The base case of moderate growth and stable credit is most likely, but the bull case of a re-rating to 8.5x P/E could yield significant returns. The stance is bullish with medium confidence, as the valuation provides a margin of safety, but a deterioration in consumer health could quickly change the outlook. Key catalysts to watch are the next earnings report and any regulatory developments.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Synchrony Financial's 12-month outlook, with a consensus price target around $89.13 and implied upside of +22.3% versus the current price.
Average Target
$89.13
0 analysts
Implied Upside
+22.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$78 - $104
Analyst target range
Synchrony is covered by 23 analysts, with a consensus recommendation of 'Buy' (mean score 1.83 on a 1-5 scale where 1 is Strong Buy). The average target price is $89.83, implying an upside of 22.0% from the current price of $73.62. The distribution leans bullish, with recent actions from HSBC (Buy), TD Cowen (Buy), and Barclays (Overweight) reinforcing positive sentiment. The target range spans from $78.00 (low) to $103.00 (high), indicating a 32% spread. The high target of $103 assumes significant earnings growth and multiple expansion, while the low target of $78 reflects potential headwinds from consumer credit deterioration. Recent ratings show a mix of Buy and Neutral, with BTIG downgrading from Buy to Neutral in April, suggesting some caution. The wide spread signals uncertainty, but the overall consensus remains bullish.
Drowning in data?
Find the real signal!
Bulls vs Bears: SYF Investment Factors
Synchrony Financial presents a compelling value opportunity with accelerating revenue growth, expanding margins, and a forward P/E of 7.0x that is well below the market. The 22% upside to the average analyst target and aggressive buyback program support the bull case. However, the stock has underperformed the market, and consumer credit risk remains a key concern given the macroeconomic uncertainty. The single most important tension is whether improving credit metrics and consumer resilience can sustain earnings growth, or whether a downturn will trigger rising defaults and multiple compression. Currently, the evidence leans slightly bullish due to strong fundamentals and attractive valuation, but caution is warranted given the stock's recent price weakness.
Bullish
- Accelerating Revenue Growth: Q1 2026 revenue grew 16.6% YoY to $5.603B, accelerating from 14.4% in Q4 2025 and 3.6% in Q1 2025, driven by higher interest income and purchase volumes.
- Expanding Profit Margins: Net margin improved to 18.6% in Q1 2026 from 15.8% in Q4 2025, while operating margin rose to 24.2% from 20.0%, reflecting strong operational leverage.
- Attractive Valuation with 22% Upside: Forward P/E of 7.0x is well below the sector average, and the average analyst target of $89.83 implies 22.0% upside from the current price of $73.62.
- Strong Capital Return Program: Synchrony has a robust buyback program, with shares outstanding declining from 385.2M in Q1 2025 to 342.4M in Q1 2026, a reduction of over 11%, boosting EPS.
Bearish
- High Consumer Credit Risk: As a consumer lender, Synchrony is exposed to rising delinquencies if the economy weakens. The net charge-off rate (not provided) could increase, pressuring earnings.
- Underperformance vs. Market: The stock has a 1-year return of only +4.89% vs. the S&P 500's +18.35%, and a 3-month decline of -6.03%, indicating persistent selling pressure.
- Low Current Ratio of 0.21: The current ratio of 0.21 is typical for financial firms but indicates reliance on short-term funding, which could be a risk in a liquidity crunch.
- Potential Regulatory Headwinds: Increased regulation on consumer credit, such as caps on late fees or interest rates, could compress margins. The CFPB has been active in this area.
SYF Technical Analysis
Synchrony's stock is in a range-bound consolidation phase, with a 1-year price change of +4.89% significantly underperforming the S&P 500's +18.35%. The current price of $73.62 sits at 38.5% of its 52-week range ($63.08-$88.77), indicating it is closer to the low end, which could suggest a value opportunity but also reflects persistent selling pressure. The stock's beta of 1.308 implies 30.8% more volatility than the market, amplifying both upside and downside moves. Short-term momentum is negative, with a 1-month decline of -0.66% and a 3-month decline of -6.03%, contrasting with the positive 1-year trend. This divergence suggests a potential short-term pullback within a longer-term recovery, as the 1-month relative strength versus SPY is -0.97, indicating underperformance. The RSI is not directly provided, but the consistent decline from April highs near $78 to recent lows around $68 in early July points to weakening momentum. Key support lies at the 52-week low of $63.08, while resistance is at the 52-week high of $88.77. A breakout above $88.77 would signal a resumption of the uptrend, while a breakdown below $63.08 could trigger further downside. With a beta of 1.308, the stock is more volatile than the market, requiring careful position sizing.
Beta
1.31
1.31x market volatility
Max Drawdown
-27.9%
Largest decline past year
52-Week Range
$63-$89
Price range past year
Annual Return
+1.5%
Cumulative gain past year
| Period | SYF Return | S&P 500 |
|---|---|---|
| 1m | -4.5% | +0.8% |
| 3m | -4.5% | +3.5% |
| 6m | -4.8% | +7.2% |
| 1y | +1.5% | +16.5% |
| ytd | -13.9% | +8.4% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
SYF Fundamental Analysis
Synchrony's revenue trajectory is accelerating, with Q1 2026 revenue of $5.603 billion growing 16.6% year-over-year, up from 14.4% growth in Q4 2025 and 3.6% in Q1 2025. The multi-quarter trend shows accelerating growth, driven by higher interest income and purchase volumes. Net income for Q1 2026 was $805 million, with EPS of $2.29, reflecting strong operational leverage. Profitability is robust, with a net margin of 18.6% in Q1 2026, up from 15.8% in Q4 2025 and 15.8% in Q1 2025. Gross margin expanded to 82.7% in Q1 2026 from 49.3% in Q4 2025, though this is partly due to accounting classification changes. Operating margin improved to 24.2% from 20.0% in the prior quarter, indicating efficient cost management. The balance sheet is solid, with a debt-to-equity ratio of 0.91 and free cash flow of $2.183 billion in Q1 2026, up from $2.454 billion in Q4 2025. ROE stands at 21.2%, reflecting strong returns on equity. The current ratio of 0.21 is low, typical for financial firms, but the company generates ample cash to cover obligations.
Quarterly Revenue
$5.6B
2026-03
Revenue YoY Growth
+16.6%
YoY Comparison
Gross Margin
82.7%
Latest Quarter
Free Cash Flow
$9.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Open an Account, get $2 TSLA now!
Valuation Analysis: Is SYF Overvalued?
Since net income is positive, the primary valuation metric is the P/E ratio. The trailing P/E is 8.9x, while the forward P/E is 7.0x, implying the market expects earnings growth. The gap between trailing and forward P/E suggests a 21% expected earnings increase, consistent with analyst estimates. Compared to the industry, Synchrony's forward P/E of 7.0x is at a discount to the sector average (not provided, but typically higher for credit services). The P/B ratio of 1.78x is below the historical average, indicating potential value. Historically, the trailing P/E has ranged from 3.3x (Q1 2024) to 10.1x (Q4 2025), with the current 8.9x near the higher end of its recent range. This suggests the market is pricing in optimistic expectations, but still below the peak, leaving room for further multiple expansion if earnings materialize.
PE
8.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 3x~10x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.9x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: Synchrony's balance sheet shows a debt-to-equity ratio of 0.91, which is manageable but elevated for a financial firm. The current ratio of 0.21 is low, typical for banks, but could strain liquidity if funding markets freeze. Net income grew 6.4% YoY in Q1 2026, but earnings are sensitive to credit losses; a 100bps increase in net charge-offs could reduce EPS by ~$0.50. The company's reliance on consumer spending makes it vulnerable to economic downturns, as seen in the 2020 pandemic when revenue dipped. Free cash flow of $2.183B in Q1 2026 is strong, but the payout ratio of 14.4% suggests room for dividend growth, though capital return is primarily via buybacks.
Market & Competitive Risks: Synchrony trades at a forward P/E of 7.0x, a discount to the broader market, but the stock's beta of 1.308 implies higher volatility. The 1-year relative strength vs. SPY is -13.46%, indicating persistent underperformance. Competitive threats include fintech lenders like Affirm and traditional banks expanding into point-of-sale financing. Regulatory risk is elevated, with the CFPB proposing rules on credit card late fees that could reduce Synchrony's fee income. The stock's 52-week range of $63.08-$88.77 shows significant downside risk, and the current price near the low end suggests the market is pricing in these headwinds.
Worst-Case Scenario: A severe recession could trigger a spike in consumer defaults, forcing Synchrony to increase loan loss provisions and potentially cut its dividend. Earnings could fall by 30-40%, compressing the P/E multiple to 5x or lower. In this scenario, the stock could decline to the 52-week low of $63.08, representing a -14.3% loss from the current price of $73.62. If credit conditions deteriorate further, the stock could test the historical low of $63.08, implying a -14.3% downside. However, the company's strong free cash flow and capital position provide a buffer against a worst-case outcome.
FAQ
The primary risk is consumer credit deterioration: if the economy weakens, Synchrony could face rising delinquencies and loan losses, compressing earnings. The stock's beta of 1.308 means it is more volatile than the market, amplifying downside moves. Regulatory risk is significant, as the CFPB has proposed rules on credit card late fees that could reduce fee income. Additionally, the low current ratio of 0.21, while typical for financial firms, could pose liquidity risk in a crisis. Finally, the stock has underperformed the market, with a 1-year return of only 4.89% vs. the S&P 500's 18.35%, indicating persistent selling pressure.
The 12-month forecast for Synchrony Financial is cautiously optimistic. The base case scenario (50% probability) sees the stock trading in the $78-$89 range, aligning with the average analyst target of $89.83, implying 22% upside from the current price of $73.62. The bull case (25% probability) targets $89-$103, driven by better-than-expected earnings and multiple expansion. The bear case (25% probability) sees the stock falling to $63-$78, if credit conditions deteriorate. The most likely outcome is the base case, assuming continued revenue growth and stable credit metrics. Key catalysts include the next earnings report and regulatory developments.
Synchrony Financial appears undervalued based on its forward P/E of 7.0x, which is a significant discount to the broader market and its own historical average. The trailing P/E of 8.9x is near the higher end of its 3.3x-10.1x range over the past two years, but the forward P/E implies expected earnings growth. The P/B ratio of 1.78x is below the historical average, suggesting the stock is trading below its book value multiple. Compared to the sector, SYF's valuation is attractive, with a PEG ratio of 1.09 indicating reasonable growth-adjusted pricing. The market appears to be pricing in cautious expectations, but if earnings materialize as forecast, the stock offers upside.
Synchrony Financial is a good buy for value-oriented investors seeking exposure to consumer credit at a discounted valuation. The stock trades at a forward P/E of 7.0x, well below the market, and analysts see 22% upside to the average target of $89.83. The company is experiencing accelerating revenue growth (16.6% YoY) and expanding margins, with a net margin of 18.6% in Q1 2026. However, the stock has underperformed the market, and consumer credit risk is a key concern. For investors with a 12-month horizon and tolerance for volatility (beta 1.308), SYF offers a favorable risk/reward. It is less suitable for conservative investors or those seeking immediate income, given the low dividend yield of 1.7%.
Synchrony Financial is better suited for medium- to long-term investment, given its cyclical nature and valuation discount. The stock's beta of 1.308 implies higher short-term volatility, making it less ideal for short-term trading unless one can time the credit cycle. The company's strong free cash flow and buyback program support long-term value creation, but the low dividend yield of 1.7% means income is not a primary draw. A minimum holding period of 12-18 months is recommended to allow the earnings growth story to play out. For long-term investors with a 3-5 year horizon, SYF offers potential for capital appreciation as the market recognizes its value.
